High incidence of mental disorders, reduced mental well‐being and cognitive function in hypopituitary women with GH deficiency treated for pituitary disease

objective Previous studies have shown possible neuroendocrine effects of GH. In the present study we investigated the incidence of mental disorders and the prevalence of mental distress and cognitive dysfunction in hypopituitary women with untreated GH deficiency compared to population‐based controls.

[1]  P. Orbaek,et al.  A comparison of neuropsychological tests for the assessment of chronic toxic encephalopathy. , 2000, American journal of industrial medicine.

[2]  P. Eriksson,et al.  Peripheral Infusion of IGF-I Selectively Induces Neurogenesis in the Adult Rat Hippocampus , 2000, The Journal of Neuroscience.

[3]  L. Hagmar,et al.  Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors. , 2000, The Journal of clinical endocrinology and metabolism.

[4]  R. Murray,et al.  Influences on quality of life in GH deficient adults and their effect on response to treatment , 1999, Clinical endocrinology.

[5]  Macfarlane,et al.  The quality of life of adults with growth hormone deficiency: comparison with diabetic patients and control subjects , 1999, Clinical endocrinology.

[6]  N. Stanhope,et al.  Cognitive effects of pituitary tumours and their treatments: two case studies and an investigation of 90 patients , 1998, Journal of neurology, neurosurgery, and psychiatry.

[7]  Peace,et al.  Cognitive dysfunction in patients with pituitary tumour who have been treated with transfrontal or transsphenoidal surgery or medication , 1998, Clinical endocrinology.

[8]  D. Schoenfeld,et al.  Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency. , 1998, The Journal of clinical endocrinology and metabolism.

[9]  T. Spinks,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society The Effects of 10 Years of Recombinant Human Growth Hormone (GH) in Adult GH-Deficient Patients , 2022 .

[10]  B. Bengtsson,et al.  Beneficial effects of long‐term GH replacement therapy on quality of life in adults with GH deficiency , 1998, Clinical endocrinology.

[11]  R. Clopper,et al.  Quality of life among formerly treated childhood-onset growth hormone-deficient adults: a comparison with unaffected siblings. , 1998, The Journal of clinical endocrinology and metabolism.

[12]  J. Deijen,et al.  Cognitive changes during growth hormone replacement in adult men , 1998, Psychoneuroendocrinology.

[13]  P. Joyce,et al.  Growth hormone replacement does not improve psychological well-being in adult hypopituitarism: A randomized crossover trial , 1998, Psychoneuroendocrinology.

[14]  J. Ranstam,et al.  Reliability and validity assessments of measures of social networks, social support and control — results from the Malmö Shoulder and Neck Study , 1997, Scandinavian journal of social medicine.

[15]  R. Edwards,et al.  Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years , 1997, Clinical endocrinology.

[16]  D. Johnston.  Growth hormone deficiency and quality of life in hypopituitary adults , 1997, Clinical endocrinology.

[17]  L. Hagmar,et al.  Increased cerebrovascular mortality in patients with hypopituitarism , 1997, Clinical endocrinology.

[18]  J. Deijen,et al.  Cognitive impairments and mood disturbances in growth hormone deficient men , 1996, Psychoneuroendocrinology.

[19]  R. Ekman,et al.  Growth hormone treatment affects brain neurotransmitters and thyroxine , 1996 .

[20]  I. Wiklund,et al.  Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial. , 1995, The Journal of clinical endocrinology and metabolism.

[21]  S. Shalet,et al.  Factors influencing the desire for long‐term growth hormone replacement in adults , 1995, Clinical endocrinology.

[22]  R. Clayton,et al.  Assessment of GH status in adults with GH deficiency using serum growth hormone, serum insulin‐like growth factor‐l and urinary growth hormone excretion , 1995, Clinical endocrinology.

[23]  S. Shalet,et al.  The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism , 1994, Clinical endocrinology.

[24]  A. O’Sullivan,et al.  Diagnosis of growth-hormone deficiency in adults , 1994, The Lancet.

[25]  I. Wiklund,et al.  Decreased psychological well‐being in adult patients with growth hormone deficiency , 1994, Clinical endocrinology.

[26]  L. Lönn,et al.  Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. , 1993, The Journal of clinical endocrinology and metabolism.

[27]  J. Batchelor,et al.  Neuropsychological abnormalities in patients with pituitary tumours , 1992, Acta neurologica Scandinavica.

[28]  M. Patterson.  Understanding Brain Damage , 1992, Neurology.

[29]  C. Boreham,et al.  Growth hormone treatment of adults withgrowth hormone deficiency: results of a 13‐month placebo controlled cross‐over study , 1992, Clinical endocrinology.

[30]  K. Hall,et al.  Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. , 1991, Acta endocrinologica.

[31]  M. Emtner,et al.  Characterization of putative growth hormone receptors in human choroid plexus , 1991, Brain Research.

[32]  M. Folstein,et al.  Cognitive impairment and functional disability in the absence of psychiatric diagnosis , 1991, Psychological Medicine.

[33]  J. Lindholm,et al.  THE INFLUENCE OF GROWTH HORMONE ON SLEEP IN ADULTS WITH GROWTH HORMONE DEFICIENCY , 1990, Clinical endocrinology.

[34]  O. Almkvist,et al.  Physical and psychological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency. , 1990, Acta endocrinologica.

[35]  G. Mcgauley.  Quality of Life Assessment Before and After Growth Hormone Treatment in Adults with Growth Hormone Deficiency , 1989, Acta paediatrica Scandinavica. Supplement.

[36]  M. Littley,et al.  Hypopituitarism following external radiotherapy for pituitary tumours in adults. , 1989, The Quarterly journal of medicine.

[37]  M. Thorén,et al.  Effects of growth hormone substitution on mental performance in adults with growth hormone deficiency: a pilot study , 1986, Psychoneuroendocrinology.

[38]  H. Libshitz,et al.  Cerebral radiation necrosis following treatment of extracranial malignancies , 1984, Cancer.

[39]  P. Duncan-Jones,et al.  Measuring social relationships The Interview Schedule for Social Interaction , 1980, Psychological Medicine.

[40]  P. Burger,et al.  The morphologic effects of radiation administered therapeutically for intracranial gliomas.A Postmortem study of 25 cases , 1979, Cancer.

[41]  Brenda Milner,et al.  Visually-guided maze learning in man: effects of bilateral hippocampal, bilateral frontal, and unilateral cerebral lesions , 1965 .

[42]  B. Cronholm,et al.  MEMORY DISTURBANCES AFTER ELECTROCONVULSIVE THERAPY , 1959 .

[43]  H. Burger,et al.  The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults. , 1998, The Journal of clinical endocrinology and metabolism.

[44]  M. Korbonits,et al.  Diagnosis of growth hormone deficiency in adults. , 1996, Hormone research.

[45]  G. Riva,et al.  Growth hormone treatment in adults with childhood onset growth hormone deficiency: effects on psychological capabilities. , 1995, Hormone research.

[46]  P. Östergren,et al.  Social network, social support and acute chest complaints among young and middle-aged patients in an emergency department--a case-control study. , 1991, Social science & medicine.

[47]  K. Orth-Gomér,et al.  Development of a social support instrument for use in population surveys. , 1989, Social science & medicine.

[48]  M. Thorén,et al.  Update on somatomedin. , 1988, Acta paediatrica Scandinavica. Supplement.

[49]  P. Östergren,et al.  Different social network and social support characteristics, nervous problems and insomnia: theoretical and methodological aspects on some results from the population study 'men born in 1914', Malmö, Sweden. , 1987, Social science & medicine.

[50]  M. Graffar.  [Modern epidemiology]. , 1971, Bruxelles medical.